Nephrology Dialysis Transplantation 2009-02-01

High-dose angiotensin-converting enzyme inhibitor attenuates oxidative stress in patients with chronic kidney disease.

Marcin Renke, Leszek Tylicki, Narcyz Knap, Przemyslaw Rutkowski, Alexander Neuwelt, Andriy Petranyuk, Wojciech Larczynski, Michał Wozniak, Boleslaw Rutkowski

Index: Nephrol. Dial. Transplant. 24(2) , 689-90, (2009)

Full Text: HTML

Abstract

Structure	Name/CAS No.	Molecular Formula	Articles
	Cilazapril Monohydrate CAS:92077-78-6	C₂₂H₃₃N₃O₆
	(1S,9S)-9-{[(2R)-1-Ethoxy-1-oxo-4-phenyl-2-butanyl]amino}-10-oxooctahydro-6H-pyridazino[1,2-a][1,2]diazepine-1-carboxylic acid CAS:106928-09-0	C₂₂H₃₁N₃O₅

Cilazapril stability in the presence of hydrochlorothiazide ...
2013-01-01
[Acta Pol. Pharm. 70(6) , 1079-85, (2013)]

Common medications among dental outpatients: considerations ...
2012-12-01
[N. Z. Dent. J. 108(4) , 140-7, (2012)]

Ultra-thin-layer chromatography mass spectrometry and thin-l...
2011-05-20
[J. Chromatogr. A. 1218(20) , 3089-94, (2011)]

[Successful treatment of polymedicamentous poisoning with me...
2009-11-01
[Vojnosanit. Pregl. 66(11) , 904-8, (2009)]

Rapid and simple stability indicating HPLC method for the de...
2012-01-01
[Acta Pol. Pharm. 69(2) , 193-201, (2012)]

High-dose angiotensin-converting enzyme inhibitor attenuates oxidative stress in patients with chronic kidney disease.

Abstract

Related Compounds